Capital expenditure increased 68.7%
Capital expenditure changed +68.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +68.7% from the comparable as-filed period.
Debt / assets changed -460 basis points from the comparable as-filed period.
Cash / debt changed -581 basis points from the comparable as-filed period.
Selling, general & administrative changed +21.7% from the comparable as-filed period.
Debt / revenue changed -1613 basis points from the comparable as-filed period.
Stock-based compensation changed +50.9% from the comparable as-filed period.
Free-cash-flow proxy changed -2600.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Capex / revenue changed +128 basis points from the comparable as-filed period.
Operating income changed -1.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed +10.0% from the comparable as-filed period.
Working capital / assets changed +117 basis points from the comparable as-filed period.
Operating cash-flow margin changed +68 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net debt changed +6.5% from the comparable as-filed period.
Current ratio changed -1.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -60 basis points from the comparable as-filed period.
Receivables / revenue changed -16 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed +14 basis points from the comparable as-filed period.
Current long-term debt changed -2.4% from the comparable as-filed period.
Gross debt changed -1.2% from the comparable as-filed period.
Reported total debt changed -1.2% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.